UNICREDIT BANK/CALL/MERCK/215/0.1/18.12.24 Share Price

Warrant

DE000HC94AA9

Real-time BOERSE MUENCHEN 01:11:13 24/05/2024 am IST
0.24 EUR +9.09% Intraday chart for UNICREDIT BANK/CALL/MERCK/215/0.1/18.12.24
Current month+175.86%
1 month+118.18%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
23/24/23 0.24 +9.09%
22/24/22 0.22 +15.79%
21/24/21 0.19 0.00%
20/24/20 0.19 -5.00%
17/24/17 0.2 0.00%

Real-time BOERSE MUENCHEN

Last update May 24, 2024 at 01:11 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HC94AA
ISINDE000HC94AA9
Date issued 07/09/2023
Strike 215
Maturity 18/12/2024 (209 Days)
Parity 10 : 1
Emission price 0.73
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.74
Lowest since issue 0.084
Spread 0.05
Spread %19.23%

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
169 EUR
Average target price
182.9 EUR
Spread / Average Target
+8.22%
Consensus